Cargando…

Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG

Background: The investigation of the antibody response to SARS-CoV-2 represents a key aspect in facing the COVID-19 pandemic. In the present study, we compared the new Immundiagnostik IDK® anti-SARS-CoV-2 S1 IgG assay with four widely-used commercial serological assays for the detection of antibodie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eberhardt, Kirsten Alexandra, Dewald, Felix, Heger, Eva, Gieselmann, Lutz, Vanshylla, Kanika, Wirtz, Maike, Kleipass, Franziska, Johannis, Wibke, Schommers, Philipp, Gruell, Henning, Brensing, Karl August, Müller, Roman-Ulrich, Augustin, Max, Lehmann, Clara, Koch, Manuel, Klein, Florian, Di Cristanziano, Veronica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067155/ https://www.ncbi.nlm.nih.gov/pubmed/33807490 http://dx.doi.org/10.3390/microorganisms9040733

Ejemplares similares

Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
por: Vanshylla, Kanika, et al.
Publicado: (2021)

Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals
por: Korenkov, Michael, et al.
Publicado: (2021)

Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
por: Kalusche, Sarah, et al.
Publicado: (2020)

Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
por: Vanshylla, Kanika, et al.
Publicado: (2022)

CD34T+ Humanized Mouse Model to Study Mucosal HIV-1 Transmission and Prevention
por: Vanshylla, Kanika, et al.
Publicado: (2021)

Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study
por: Augustin, Max, et al.
Publicado: (2021)

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing response against SARS-CoV-2 Omicron BA.5 and XBB.1.5 in hemodialysis patients
por: Affeldt, Patrick, et al.
Publicado: (2023)

CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2023)

No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults
por: Ercanoglu, Meryem Seda, et al.
Publicado: (2022)

Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
por: Tober-Lau, Pinkus, et al.
Publicado: (2022)

SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
por: Gruell, Henning, et al.
Publicado: (2022)

Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody
por: Meijers, Matthijs, et al.
Publicado: (2021)

Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients
por: Affeldt, Patrick, et al.
Publicado: (2021)

Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients
por: Affeldt, Patrick, et al.
Publicado: (2022)

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
por: Kreer, Christoph, et al.
Publicado: (2020)

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
por: Kreer, Christoph, et al.
Publicado: (2020)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
por: LaMont, Colin, et al.
Publicado: (2022)

15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study
por: Augustin, Max, et al.
Publicado: (2023)

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
por: Gruell, Henning, et al.
Publicado: (2022)

RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2020)

Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals
por: Kreer, Christoph, et al.
Publicado: (2023)

Safe and effective pool testing for SARS-CoV-2 detection
por: Wunsch, Marie, et al.
Publicado: (2021)

Molecular Characterization and Clinical Description of Non-Polio Enteroviruses Detected in Stool Samples from HIV-Positive and HIV-Negative Adults in Ghana
por: Di Cristanziano, Veronica, et al.
Publicado: (2020)

Immunoassay for quantification of antigen-specific IgG fucosylation
por: Šuštić, Tonći, et al.
Publicado: (2022)

Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients
por: Di Cristanziano, Veronica, et al.
Publicado: (2021)

Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation
por: Affeldt, Patrick, et al.
Publicado: (2021)

Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19
por: Mellinghoff, Sibylle C., et al.
Publicado: (2021)

Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
por: Schommers, Philipp, et al.
Publicado: (2020)

Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
por: Vanshylla, Kanika, et al.
Publicado: (2022)

Preliminary multiplex microarray IgG immunoassay for the diagnosis of toxoplasmosis and rubella
por: Baschirotto, Priscila T, et al.
Publicado: (2017)

Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases
por: Basile, Alison J., et al.
Publicado: (2013)

Gamma heavy chain disease in a patient with rheumatoid arthritis – a laboratory evaluation
por: Johannis, Wibke, et al.
Publicado: (2012)

SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
por: Thibeault, Charlotte, et al.
Publicado: (2023)

Analysis of Human Gut Microbiota Composition Associated to the Presence of Commensal and Pathogen Microorganisms in Côte d’Ivoire
por: Di Cristanziano, Veronica, et al.
Publicado: (2021)

Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
por: Tober-Lau, Pinkus, et al.
Publicado: (2021)

Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays
por: Wellinghausen, Nele, et al.
Publicado: (2020)

Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays
por: Tanis, Jorg, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jo7mt1ppd750q9mp945ne397rc